Log in
Email Address
Password
Forgot your password?
Not Registered?

Featured Tenants

 cfai

The Centre for Advanced Instrumentation at the NETPark Research Institute collaborates with observatories world-wide in the construction, commissioning and exploitation of innovative hi-tech instruments for optical and infrared astronomy. Key research areas are advanced spectroscopy, adaptive optics, applied optics, low light level detectors and precision engineering/metrology.

Click here to learn more about Centre for Advanced Instrumentation

Featured Opportunity
Provision of value innovation specialist support to SME members of NETPark Net

The aim of this contract is to provide individual and tailored support to members of NETPark Net.  This service is expected to be focused on unlocking innovation within the existing operations of the companies and using this discovered potential to increase turnover and profitability, and create jobs.  For further information click here

The deadline is 11th July 2008

Polls



CDEP logo

cddc   eu

Gene therapy hope for blindness
Bookmark and Share Add This     email Email a Friend    print Printable version

Gene therapy hope for blindness

2008-04-28
Newsfeed

Thousands of people who suffer from inherited blindness have been offered hope with breakthrough gene therapy.


Thousands of people who suffer from inherited blindness have been offered hope with breakthrough gene therapy.

A medical trial has been carried out which involved inserting genes into patient's eyes to correct a genetic fault which stops retinas detecting light properly.

The three patients experienced vision at least equivalent to before the operation, but one patient benefited significantly.

Steven Howarth, 18, said: "At first I could not see anything in the eye that was operated on but it got much better after a week, then gradually even better until it was back to normal.

"Now, my sight when it's getting dark or it's badly lit is definitely better. It's a small change but it makes a big difference."

The research was carried out by the University College London Institute of Ophthalmology and Moorfields Eye Hospital, which received £1 million from the Department of Health.

Team leader Professor Robin Ali said: "Showing that gene therapy can work in patients with eye disease is a very significant milestone.

"This trial establishes proof of principle of gene therapy for inherited retinal disease and paves the way for the development of gene therapy approaches for a broad range of eye disorders."

Copyright © The Press Association 2008